Volumetric Pouch Study After Laparoscopic Sleeve Gastrectomy

Sponsor
Kafrelsheikh University (Other)
Overall Status
Completed
CT.gov ID
NCT04880902
Collaborator
(none)
40
1
1
24
1.7

Study Details

Study Description

Brief Summary

This study aimed to evaluate Laparoscopic Sleeve Gastrectomy in the treatment of morbidly obese patients pre and post-operatively after 3 months, 6 months, and 1-year follow-up and assess the volumetric changes of the gastric reservoir 1 year after LSG using multi-slice computer tomography.

Condition or Disease Intervention/Treatment Phase
  • Procedure: sleeve gastrectomy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Volumetric Pouch Study After Laparoscopic Sleeve Gastrectomy: Effect of the Pouch Size on Excessive Weight Loss and Weight Regain
Actual Study Start Date :
Nov 1, 2018
Actual Primary Completion Date :
Oct 1, 2020
Actual Study Completion Date :
Nov 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: sleeve gastrectomy followed by volumetric assessment

Procedure: sleeve gastrectomy
Laparoscopic sleeve gastrectomy had evident therapeutic effects on preexisting obesity-related comorbidities. All patients were referred for abdominal MSCT with a volumetric assessment of gastric pouch within 1 month of surgery and 1 year postoperatively

Outcome Measures

Primary Outcome Measures

  1. Gastric volume after surgery [1 month]

    gastric reservoir volume after performance of laparoscopic sleeve gastrectomy

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • BMI of > 40 kg/m 2 or > 35 kg/m2 with comorbidities e.g. hypertension and type 2 DM.

  • All patients failed in supervised conservative management for obesity for at least 2 years.

Exclusion Criteria:
  • BMI > 60

  • previous bariatric surgery

  • symptomatic reflux oesophagitis disease, gastric pathology (tumor, active peptic ulcer)

  • Significant psychological disorder, active alcohol or substance abuse

  • severe eating disorders (bulimia)

  • severe systemic disease making anesthesia or surgery prohibitively risky (American Society of Anesthesiologists (ASA) class IV

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kafrelsheikh university Kafr Ash Shaykh Egypt 33516

Sponsors and Collaborators

  • Kafrelsheikh University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mohamed Ahmed Elkhoby, Dr, assistant lecturer of General Surgery, Kafrelsheikh University
ClinicalTrials.gov Identifier:
NCT04880902
Other Study ID Numbers:
  • 01006786978123
First Posted:
May 11, 2021
Last Update Posted:
May 11, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mohamed Ahmed Elkhoby, Dr, assistant lecturer of General Surgery, Kafrelsheikh University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 11, 2021